Titre : Hydrocortisone

Hydrocortisone : Questions médicales fréquentes

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une insuffisance surrénalienne ?

Un test de stimulation à l'ACTH et des dosages de cortisol sont effectués.
Insuffisance surrénalienne Cortisol
#2

Quels tests pour évaluer l'excès de cortisol ?

Des tests de cortisol libre urinaire et un test de suppression à la dexaméthasone sont utilisés.
Cortisol Syndrome de Cushing
#3

Quels symptômes indiquent un besoin d'hydrocortisone ?

Fatigue, perte de poids, hypotension et douleurs abdominales peuvent indiquer un besoin.
Fatigue Hypotension
#4

Comment évaluer une réaction allergique ?

Un examen clinique et des tests cutanés peuvent aider à diagnostiquer une allergie.
Réaction allergique Tests cutanés
#5

Quels signes d'inflammation nécessitent un traitement ?

Rougeur, chaleur, gonflement et douleur persistante peuvent nécessiter un traitement.
Inflammation Douleur

Symptômes 5

#1

Quels sont les effets secondaires courants de l'hydrocortisone ?

Prise de poids, hypertension, troubles du sommeil et changements d'humeur sont fréquents.
Effets secondaires Hypertension
#2

Comment l'hydrocortisone affecte-t-elle le métabolisme ?

Elle peut augmenter la glycémie et modifier le métabolisme des lipides et des protéines.
Métabolisme Glycémie
#3

Quels symptômes indiquent une surdose d'hydrocortisone ?

Symptômes incluent hypertension, hyperglycémie, et troubles psychologiques.
Surdose Hypertension
#4

Quels signes d'infection sont à surveiller ?

Fièvre, frissons, et fatigue excessive peuvent indiquer une infection sous-jacente.
Infection Fièvre
#5

Quels symptômes d'une réaction allergique à l'hydrocortisone ?

Éruptions cutanées, démangeaisons, et gonflement peuvent survenir lors d'une allergie.
Réaction allergique Éruption cutanée

Prévention 5

#1

Comment prévenir les effets secondaires de l'hydrocortisone ?

Utiliser la dose minimale efficace et surveiller régulièrement les paramètres de santé.
Prévention Effets secondaires
#2

Quelles précautions avant de commencer l'hydrocortisone ?

Informer le médecin des antécédents médicaux, allergies et médicaments en cours.
Antécédents médicaux Allergies
#3

Comment éviter les infections sous traitement ?

Pratiquer une bonne hygiène et éviter les contacts avec des personnes malades.
Infections Hygiène
#4

Quels conseils pour une alimentation saine sous hydrocortisone ?

Favoriser les aliments riches en potassium et faibles en sodium pour contrer les effets.
Alimentation Potassium
#5

Comment gérer le stress pendant le traitement ?

Pratiquer des techniques de relaxation et d'exercice régulier pour réduire le stress.
Stress Techniques de relaxation

Traitements 5

#1

Comment administrer l'hydrocortisone ?

Elle peut être administrée par voie orale, intraveineuse ou topique selon l'indication.
Administration Voie intraveineuse
#2

Quelle est la posologie standard d'hydrocortisone ?

La posologie varie selon la condition, généralement de 20 à 240 mg par jour.
Posologie Corticostéroïdes
#3

Quels traitements alternatifs à l'hydrocortisone ?

D'autres corticostéroïdes ou immunosuppresseurs peuvent être envisagés selon la condition.
Immunosuppresseurs Corticostéroïdes
#4

Comment gérer les effets secondaires de l'hydrocortisone ?

Surveiller régulièrement la pression artérielle et la glycémie, ajuster la dose si nécessaire.
Effets secondaires Surveillance
#5

Quand faut-il réduire la dose d'hydrocortisone ?

Réduire la dose lors de l'apparition d'effets secondaires graves ou d'amélioration des symptômes.
Réduction de dose Effets secondaires

Complications 5

#1

Quelles sont les complications possibles de l'hydrocortisone ?

Ostéoporose, diabète, et infections opportunistes sont des complications possibles.
Ostéoporose Diabète
#2

Comment l'hydrocortisone peut-elle affecter la santé osseuse ?

Elle peut réduire la densité osseuse, augmentant le risque de fractures.
Santé osseuse Fractures
#3

Quels risques d'une utilisation prolongée d'hydrocortisone ?

L'utilisation prolongée peut entraîner des troubles endocriniens et métaboliques.
Utilisation prolongée Troubles endocriniens
#4

Comment surveiller les complications liées à l'hydrocortisone ?

Des examens réguliers de la densité osseuse et des tests de glycémie sont recommandés.
Surveillance Densité osseuse
#5

Quels signes d'une infection opportuniste ?

Fièvre persistante, fatigue et symptômes respiratoires peuvent indiquer une infection.
Infection opportuniste Fièvre

Facteurs de risque 5

#1

Qui est à risque d'effets secondaires de l'hydrocortisone ?

Les personnes âgées, celles avec des antécédents de maladies métaboliques sont à risque.
Personnes âgées Maladies métaboliques
#2

Quels médicaments augmentent les risques avec l'hydrocortisone ?

Les anticoagulants et certains diurétiques peuvent interagir avec l'hydrocortisone.
Anticoagulants Diurétiques
#3

Comment le mode de vie influence-t-il les effets de l'hydrocortisone ?

Un mode de vie sédentaire et une mauvaise alimentation peuvent aggraver les effets secondaires.
Mode de vie Alimentation
#4

Quels antécédents médicaux augmentent les risques ?

Antécédents d'ulcères, de diabète ou d'hypertension augmentent les risques d'effets secondaires.
Antécédents médicaux Ulcères
#5

Comment le stress affecte-t-il le traitement par hydrocortisone ?

Le stress peut aggraver les symptômes et augmenter la nécessité de corticostéroïdes.
Stress Corticostéroïdes
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hydrocortisone : Questions médicales les plus fréquentes", "headline": "Hydrocortisone : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hydrocortisone : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-01", "dateModified": "2026-04-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hydrocortisone" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "17-Hydroxycorticostéroïdes", "url": "https://questionsmedicales.fr/mesh/D015065", "about": { "@type": "MedicalCondition", "name": "17-Hydroxycorticostéroïdes", "code": { "@type": "MedicalCode", "code": "D015065", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D06.472.040.585.478" } } }, "about": { "@type": "MedicalCondition", "name": "Hydrocortisone", "alternateName": "Hydrocortisone", "code": { "@type": "MedicalCode", "code": "D006854", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Balasubramanian Venkatesh", "url": "https://questionsmedicales.fr/author/Balasubramanian%20Venkatesh", "affiliation": { "@type": "Organization", "name": "Department of Intensive Care, The Wesley Hospital, Coronation Drive, QLD 4066, Australia; Department of Intensive Care, Princess Alexandra Hospital, Ipswich Road, University of Queensland, QLD 4102, Australia; Division of Critical Care, The George Institute for Global Health, University of New South Wales, King Street, NSW 2050, Australia. Electronic address: bvenkatesh@georgeinstitute.org.au." } }, { "@type": "Person", "name": "Jeremy Cohen", "url": "https://questionsmedicales.fr/author/Jeremy%20Cohen", "affiliation": { "@type": "Organization", "name": "Department of Intensive Care, The Wesley Hospital, Coronation Drive, QLD 4066, Australia; Department of Intensive Care, The Royal Brisbane and Women's Hospital, University of Queensland, Herston Road, QLD 4066, Australia; Division of Critical Care, The George Institute for Global Health, King Street, Sydney, NSW 2050, Australia." } }, { "@type": "Person", "name": "Sophie Metz", "url": "https://questionsmedicales.fr/author/Sophie%20Metz", "affiliation": { "@type": "Organization", "name": "Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Klinik für Psychiatrie und Psychotherapie, Campus Benjamin Franklin, Berlin, Germany." } }, { "@type": "Person", "name": "Christian Otte", "url": "https://questionsmedicales.fr/author/Christian%20Otte", "affiliation": { "@type": "Organization", "name": "Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Klinik für Psychiatrie und Psychotherapie, Campus Benjamin Franklin, Berlin, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Pulsatile Subcutaneous Hydrocortisone Replacement in Primary Adrenal Insufficiency.", "datePublished": "2023-05-12", "url": "https://questionsmedicales.fr/article/37172949", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-2092-5228" } }, { "@type": "ScholarlyArticle", "name": "The Association of Dexamethasone and Hydrocortisone with Cerebellar Growth in Premature Infants.", "datePublished": "2023-06-28", "url": "https://questionsmedicales.fr/article/37379806", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000531075" } }, { "@type": "ScholarlyArticle", "name": "The effects of hydrocortisone and yohimbine on human behavior in approach-avoidance conflicts.", "datePublished": "2023-06-14", "url": "https://questionsmedicales.fr/article/37314480", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00213-023-06396-6" } }, { "@type": "ScholarlyArticle", "name": "The Timing of Initiating Hydrocortisone and Long-term Mortality in Septic Shock.", "datePublished": "2023-05-12", "url": "https://questionsmedicales.fr/article/37171987", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1213/ANE.0000000000006516" } }, { "@type": "ScholarlyArticle", "name": "Interaction of hydrocortisone and illness severity on head growth in cohort of ELBW infants.", "datePublished": "2023-06-20", "url": "https://questionsmedicales.fr/article/37340101", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41390-023-02689-w" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Hormones corticosurrénaliennes", "item": "https://questionsmedicales.fr/mesh/D000305" }, { "@type": "ListItem", "position": 3, "name": "Hydroxycorticostéroïdes", "item": "https://questionsmedicales.fr/mesh/D006889" }, { "@type": "ListItem", "position": 4, "name": "17-Hydroxycorticostéroïdes", "item": "https://questionsmedicales.fr/mesh/D015065" }, { "@type": "ListItem", "position": 5, "name": "Hydrocortisone", "item": "https://questionsmedicales.fr/mesh/D006854" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hydrocortisone - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hydrocortisone", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hydrocortisone", "description": "Comment diagnostiquer une insuffisance surrénalienne ?\nQuels tests pour évaluer l'excès de cortisol ?\nQuels symptômes indiquent un besoin d'hydrocortisone ?\nComment évaluer une réaction allergique ?\nQuels signes d'inflammation nécessitent un traitement ?", "url": "https://questionsmedicales.fr/mesh/D006854#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hydrocortisone", "description": "Quels sont les effets secondaires courants de l'hydrocortisone ?\nComment l'hydrocortisone affecte-t-elle le métabolisme ?\nQuels symptômes indiquent une surdose d'hydrocortisone ?\nQuels signes d'infection sont à surveiller ?\nQuels symptômes d'une réaction allergique à l'hydrocortisone ?", "url": "https://questionsmedicales.fr/mesh/D006854#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hydrocortisone", "description": "Comment prévenir les effets secondaires de l'hydrocortisone ?\nQuelles précautions avant de commencer l'hydrocortisone ?\nComment éviter les infections sous traitement ?\nQuels conseils pour une alimentation saine sous hydrocortisone ?\nComment gérer le stress pendant le traitement ?", "url": "https://questionsmedicales.fr/mesh/D006854#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hydrocortisone", "description": "Comment administrer l'hydrocortisone ?\nQuelle est la posologie standard d'hydrocortisone ?\nQuels traitements alternatifs à l'hydrocortisone ?\nComment gérer les effets secondaires de l'hydrocortisone ?\nQuand faut-il réduire la dose d'hydrocortisone ?", "url": "https://questionsmedicales.fr/mesh/D006854#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hydrocortisone", "description": "Quelles sont les complications possibles de l'hydrocortisone ?\nComment l'hydrocortisone peut-elle affecter la santé osseuse ?\nQuels risques d'une utilisation prolongée d'hydrocortisone ?\nComment surveiller les complications liées à l'hydrocortisone ?\nQuels signes d'une infection opportuniste ?", "url": "https://questionsmedicales.fr/mesh/D006854#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hydrocortisone", "description": "Qui est à risque d'effets secondaires de l'hydrocortisone ?\nQuels médicaments augmentent les risques avec l'hydrocortisone ?\nComment le mode de vie influence-t-il les effets de l'hydrocortisone ?\nQuels antécédents médicaux augmentent les risques ?\nComment le stress affecte-t-il le traitement par hydrocortisone ?", "url": "https://questionsmedicales.fr/mesh/D006854#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une insuffisance surrénalienne ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un test de stimulation à l'ACTH et des dosages de cortisol sont effectués." } }, { "@type": "Question", "name": "Quels tests pour évaluer l'excès de cortisol ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de cortisol libre urinaire et un test de suppression à la dexaméthasone sont utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent un besoin d'hydrocortisone ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, perte de poids, hypotension et douleurs abdominales peuvent indiquer un besoin." } }, { "@type": "Question", "name": "Comment évaluer une réaction allergique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Un examen clinique et des tests cutanés peuvent aider à diagnostiquer une allergie." } }, { "@type": "Question", "name": "Quels signes d'inflammation nécessitent un traitement ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, chaleur, gonflement et douleur persistante peuvent nécessiter un traitement." } }, { "@type": "Question", "name": "Quels sont les effets secondaires courants de l'hydrocortisone ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Prise de poids, hypertension, troubles du sommeil et changements d'humeur sont fréquents." } }, { "@type": "Question", "name": "Comment l'hydrocortisone affecte-t-elle le métabolisme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut augmenter la glycémie et modifier le métabolisme des lipides et des protéines." } }, { "@type": "Question", "name": "Quels symptômes indiquent une surdose d'hydrocortisone ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Symptômes incluent hypertension, hyperglycémie, et troubles psychologiques." } }, { "@type": "Question", "name": "Quels signes d'infection sont à surveiller ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, frissons, et fatigue excessive peuvent indiquer une infection sous-jacente." } }, { "@type": "Question", "name": "Quels symptômes d'une réaction allergique à l'hydrocortisone ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Éruptions cutanées, démangeaisons, et gonflement peuvent survenir lors d'une allergie." } }, { "@type": "Question", "name": "Comment prévenir les effets secondaires de l'hydrocortisone ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser la dose minimale efficace et surveiller régulièrement les paramètres de santé." } }, { "@type": "Question", "name": "Quelles précautions avant de commencer l'hydrocortisone ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Informer le médecin des antécédents médicaux, allergies et médicaments en cours." } }, { "@type": "Question", "name": "Comment éviter les infections sous traitement ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Pratiquer une bonne hygiène et éviter les contacts avec des personnes malades." } }, { "@type": "Question", "name": "Quels conseils pour une alimentation saine sous hydrocortisone ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Favoriser les aliments riches en potassium et faibles en sodium pour contrer les effets." } }, { "@type": "Question", "name": "Comment gérer le stress pendant le traitement ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Pratiquer des techniques de relaxation et d'exercice régulier pour réduire le stress." } }, { "@type": "Question", "name": "Comment administrer l'hydrocortisone ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut être administrée par voie orale, intraveineuse ou topique selon l'indication." } }, { "@type": "Question", "name": "Quelle est la posologie standard d'hydrocortisone ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La posologie varie selon la condition, généralement de 20 à 240 mg par jour." } }, { "@type": "Question", "name": "Quels traitements alternatifs à l'hydrocortisone ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "D'autres corticostéroïdes ou immunosuppresseurs peuvent être envisagés selon la condition." } }, { "@type": "Question", "name": "Comment gérer les effets secondaires de l'hydrocortisone ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Surveiller régulièrement la pression artérielle et la glycémie, ajuster la dose si nécessaire." } }, { "@type": "Question", "name": "Quand faut-il réduire la dose d'hydrocortisone ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Réduire la dose lors de l'apparition d'effets secondaires graves ou d'amélioration des symptômes." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de l'hydrocortisone ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Ostéoporose, diabète, et infections opportunistes sont des complications possibles." } }, { "@type": "Question", "name": "Comment l'hydrocortisone peut-elle affecter la santé osseuse ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut réduire la densité osseuse, augmentant le risque de fractures." } }, { "@type": "Question", "name": "Quels risques d'une utilisation prolongée d'hydrocortisone ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "L'utilisation prolongée peut entraîner des troubles endocriniens et métaboliques." } }, { "@type": "Question", "name": "Comment surveiller les complications liées à l'hydrocortisone ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des examens réguliers de la densité osseuse et des tests de glycémie sont recommandés." } }, { "@type": "Question", "name": "Quels signes d'une infection opportuniste ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre persistante, fatigue et symptômes respiratoires peuvent indiquer une infection." } }, { "@type": "Question", "name": "Qui est à risque d'effets secondaires de l'hydrocortisone ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées, celles avec des antécédents de maladies métaboliques sont à risque." } }, { "@type": "Question", "name": "Quels médicaments augmentent les risques avec l'hydrocortisone ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les anticoagulants et certains diurétiques peuvent interagir avec l'hydrocortisone." } }, { "@type": "Question", "name": "Comment le mode de vie influence-t-il les effets de l'hydrocortisone ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sédentaire et une mauvaise alimentation peuvent aggraver les effets secondaires." } }, { "@type": "Question", "name": "Quels antécédents médicaux augmentent les risques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Antécédents d'ulcères, de diabète ou d'hypertension augmentent les risques d'effets secondaires." } }, { "@type": "Question", "name": "Comment le stress affecte-t-il le traitement par hydrocortisone ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut aggraver les symptômes et augmenter la nécessité de corticostéroïdes." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 21/04/2026

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Balasubramanian Venkatesh

3 publications dans cette catégorie

Affiliations :
  • Department of Intensive Care, The Wesley Hospital, Coronation Drive, QLD 4066, Australia; Department of Intensive Care, Princess Alexandra Hospital, Ipswich Road, University of Queensland, QLD 4102, Australia; Division of Critical Care, The George Institute for Global Health, University of New South Wales, King Street, NSW 2050, Australia. Electronic address: bvenkatesh@georgeinstitute.org.au.

Jeremy Cohen

3 publications dans cette catégorie

Affiliations :
  • Department of Intensive Care, The Wesley Hospital, Coronation Drive, QLD 4066, Australia; Department of Intensive Care, The Royal Brisbane and Women's Hospital, University of Queensland, Herston Road, QLD 4066, Australia; Division of Critical Care, The George Institute for Global Health, King Street, Sydney, NSW 2050, Australia.

Sophie Metz

3 publications dans cette catégorie

Affiliations :
  • Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Klinik für Psychiatrie und Psychotherapie, Campus Benjamin Franklin, Berlin, Germany.

Christian Otte

3 publications dans cette catégorie

Affiliations :
  • Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Klinik für Psychiatrie und Psychotherapie, Campus Benjamin Franklin, Berlin, Germany.

Katja Wingenfeld

3 publications dans cette catégorie

Affiliations :
  • Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Klinik für Psychiatrie und Psychotherapie, Campus Benjamin Franklin, Berlin, Germany. Electronic address: katja.wingenfeld@charite.de.

Nicholas A Bosch

2 publications dans cette catégorie

Affiliations :
  • The Pulmonary Center, Boston University Chobanian & Avedisian School of Medicine, Department of Medicine, Boston, Massachusetts.
Publications dans "Hydrocortisone" :

Bijan Teja

2 publications dans cette catégorie

Affiliations :
  • Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario.
  • Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario.
Publications dans "Hydrocortisone" :

Anica C Law

2 publications dans cette catégorie

Affiliations :
  • The Pulmonary Center, Boston University Chobanian & Avedisian School of Medicine, Department of Medicine, Boston, Massachusetts.
Publications dans "Hydrocortisone" :

Brandon Pang

2 publications dans cette catégorie

Affiliations :
  • The Pulmonary Center, Boston University Chobanian & Avedisian School of Medicine, Department of Medicine, Boston, Massachusetts.
Publications dans "Hydrocortisone" :

Allan J Walkey

2 publications dans cette catégorie

Affiliations :
  • The Pulmonary Center, Boston University Chobanian & Avedisian School of Medicine, Department of Medicine, Boston, Massachusetts.
Publications dans "Hydrocortisone" :

Olivier Baud

2 publications dans cette catégorie

Affiliations :
  • Division of Neonatology and Pediatric Intensive Care, University Hospitals Geneva, Geneva, Switzerland. Electronic address: olivier.baud@hcuge.ch.
Publications dans "Hydrocortisone" :

Kristi L Watterberg

2 publications dans cette catégorie

Affiliations :
  • Division of Neonatology, Department of Pediatrics, University of New Mexico School of Medicine, Albuquerque, NM, USA.
Publications dans "Hydrocortisone" :

Ronald N Goldberg

2 publications dans cette catégorie

Affiliations :
  • From the University of New Mexico Health Sciences Center, Albuquerque (K.L.W., C.B.-L., J.R.L.); the Department of Pediatrics, Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland (M.C.W., A.M.H., D.E.W.-C.), Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati (B.B.P., S.M.), and the Department of Pediatrics, Nationwide Children's Hospital, Ohio State University College of Medicine, Columbus (M.M., N.L.M.) - all in Ohio; the Social, Statistical, and Environmental Sciences Unit, RTI International, Research Triangle Park (L.L.), the Department of Pediatrics, Duke University, Durham (R.N.G., C.M.C., W.F.M.), and the Division of Neonatal-Perinatal Medicine, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill (M.M.L.) - all in North Carolina; the Department of Pediatrics, Wayne State University (S.C., G.N.), and the Department of Pediatrics, Central Michigan University (S.C.) - both in Detroit; the University of Rochester School of Medicine and Dentistry, Rochester (C.T.D., P.R.C.), and the Department of Pediatrics, University of Buffalo Women's and Children's Hospital of Buffalo, Buffalo (A.M.R.) - both in New York; the Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine and Lucile Packard Children's Hospital, Palo Alto (S.R.H., K.P.V.M.), and the Department of Pediatrics, University of California, Los Angeles, Los Angeles (M.G., I.B.P.) - both in California; the Department of Pediatrics, Division of Neonatology, University of Utah School of Medicine, Salt Lake City (B.A.Y., S.W.); the Department of Pediatrics, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston (K.A.K., G.E.M., A.M.K., R.A.M.), and the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (M.H.W., R.J.H.) - both in Texas; the Social, Statistical, and Environmental Sciences Unit, RTI International, Rockville (A.D., M.M.C.), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda (R.D.H.) - both in Maryland; the Department of Pediatrics, Women and Infants Hospital, Brown University, Providence, RI (M.K., E.C.M.); the Department of Pediatrics, Indiana University School of Medicine, Indianapolis (G.M.S., A.C.H.); Emory University School of Medicine, Department of Pediatrics, Children's Healthcare of Atlanta, Atlanta (B.B.P., R.M.P., N.L.M., I.A.-C.); the Division of Neonatology, University of Alabama at Birmingham, Birmingham (N.A., M.P.-C.); the Department of Pediatrics, Children's Mercy Hospital, Kansas City, MO (W.E.T., H.W.K.); the Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia (B.S., S.B.D.); the Department of Pediatrics, University of Iowa, Iowa City (E.F.B., H.M.H.); the Department of Pediatrics, Sanford School of Medicine, University of South Dakota, Sioux Falls (L.R.M., L.A.H.); and the College of Health and Human Services, George Mason University, Fairfax, VA (R.D.H.).
Publications dans "Hydrocortisone" :

Matthew M Laughon

2 publications dans cette catégorie

Affiliations :
  • From the University of New Mexico Health Sciences Center, Albuquerque (K.L.W., C.B.-L., J.R.L.); the Department of Pediatrics, Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland (M.C.W., A.M.H., D.E.W.-C.), Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati (B.B.P., S.M.), and the Department of Pediatrics, Nationwide Children's Hospital, Ohio State University College of Medicine, Columbus (M.M., N.L.M.) - all in Ohio; the Social, Statistical, and Environmental Sciences Unit, RTI International, Research Triangle Park (L.L.), the Department of Pediatrics, Duke University, Durham (R.N.G., C.M.C., W.F.M.), and the Division of Neonatal-Perinatal Medicine, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill (M.M.L.) - all in North Carolina; the Department of Pediatrics, Wayne State University (S.C., G.N.), and the Department of Pediatrics, Central Michigan University (S.C.) - both in Detroit; the University of Rochester School of Medicine and Dentistry, Rochester (C.T.D., P.R.C.), and the Department of Pediatrics, University of Buffalo Women's and Children's Hospital of Buffalo, Buffalo (A.M.R.) - both in New York; the Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine and Lucile Packard Children's Hospital, Palo Alto (S.R.H., K.P.V.M.), and the Department of Pediatrics, University of California, Los Angeles, Los Angeles (M.G., I.B.P.) - both in California; the Department of Pediatrics, Division of Neonatology, University of Utah School of Medicine, Salt Lake City (B.A.Y., S.W.); the Department of Pediatrics, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston (K.A.K., G.E.M., A.M.K., R.A.M.), and the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (M.H.W., R.J.H.) - both in Texas; the Social, Statistical, and Environmental Sciences Unit, RTI International, Rockville (A.D., M.M.C.), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda (R.D.H.) - both in Maryland; the Department of Pediatrics, Women and Infants Hospital, Brown University, Providence, RI (M.K., E.C.M.); the Department of Pediatrics, Indiana University School of Medicine, Indianapolis (G.M.S., A.C.H.); Emory University School of Medicine, Department of Pediatrics, Children's Healthcare of Atlanta, Atlanta (B.B.P., R.M.P., N.L.M., I.A.-C.); the Division of Neonatology, University of Alabama at Birmingham, Birmingham (N.A., M.P.-C.); the Department of Pediatrics, Children's Mercy Hospital, Kansas City, MO (W.E.T., H.W.K.); the Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia (B.S., S.B.D.); the Department of Pediatrics, University of Iowa, Iowa City (E.F.B., H.M.H.); the Department of Pediatrics, Sanford School of Medicine, University of South Dakota, Sioux Falls (L.R.M., L.A.H.); and the College of Health and Human Services, George Mason University, Fairfax, VA (R.D.H.).

Richard J Ross

2 publications dans cette catégorie

Affiliations :
  • University of Sheffield, Sheffield, UK.
  • Diurnal Ltd, Cardiff, UK.
Publications dans "Hydrocortisone" :

Djillali Annane

2 publications dans cette catégorie

Affiliations :
  • School of Medicine, Versailles Saint-Quentin-en-Yvelines University, Versailles, Île-de-France, France djillali.annane@aphp.fr.
  • Universite Paris-Saclay, Saint-Aubin, Île-de-France, France.

Romain Pirracchio

2 publications dans cette catégorie

Affiliations :
  • Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, USA.

Laurent Billot

2 publications dans cette catégorie

Affiliations :
  • Statistics Division, The George Institute for Global Health, Newtown, New South Wales, Australia.

Simon Finfer

2 publications dans cette catégorie

Affiliations :
  • The George Institute for Global Health, Newtown, New South Wales, Australia.

Sources (503 au total)

The Association of Dexamethasone and Hydrocortisone with Cerebellar Growth in Premature Infants.

Corticosteroids are used to prevent or treat lung disease of prematurity. While neurological side effects have been reported, detailed effects on cerebellar growth are unknown. This study aimed to com... Retrospective case-control study in infants born at a gestational age of <29 weeks and admitted to two level 3 neonatal intensive care units. Exclusion criteria were severe congenital anomalies and... 346 infants were included (68 dexamethasone, 37 hydrocortisone, 241 controls). Before starting corticosteroids, TCD, BPD, and HC measurements did not differ between patients and controls at a comparab... Administration of dexamethasone and hydrocortisone are both associated with impaired cerebellar growth in premature infants without evident negative associations with cerebral growth....

The effects of hydrocortisone and yohimbine on human behavior in approach-avoidance conflicts.

Balancing approach of positive and avoidance of negative stimuli is essential when faced with approach-avoidance conflicts, e.g., situations with both positive and negative outcomes. This balance is d... Investigate how the pharmacological manipulation of major stress mediators (cortisol and noradrenaline) influences task-based approach-avoidance conflict behavior in healthy individuals.... Ninety-six participants (48 women, 48 men) received either 20mg hydrocortisone, 20mg yohimbine, both, or placebo before performing a task targeting foraging under predation in a fully crossed double-b... While biological stress markers (cortisol concentration, alpha amylase activity) indicated successful pharmacological manipulation, behavior in approach-avoidance conflicts was not affected as expecte... The investigated major stress mediators were not sufficient to imitate previously shown stress effects on approach-avoidance conflict behavior. We discuss potential reasons for our findings and implic...

The Timing of Initiating Hydrocortisone and Long-term Mortality in Septic Shock.

Previous studies on the association between the timing of corticosteroid administration and mortality in septic shock focused only on short-term mortality and produced conflicting results. We performe... Data were extracted from the Medical Information Mart in the Intensive Care-IV database. We included adults who met Sepsis-3 definition for septic shock and received hydrocortisone. The exposure of in... A total of 844 patients were included in this cohort: 553 in the early group and 291 in the late group. The median time to hydrocortisone initiation was 7 hours (interquartile range, 2.0-19.0 hours). ... In patients with septic shock, initiating hydrocortisone >12 hours after vasopressor use was associated with an increased risk of both short-term and long-term mortality, and a prolonged length of hos...

Interaction of hydrocortisone and illness severity on head growth in cohort of ELBW infants.

Extremely low birth weight (ELBW) infants comprise a fragile population at risk for neurodevelopmental disabilities (NDD). Systemic steroids were previously associated with NDD, but more recent studie... We conducted a retrospective study that included infants born at 23-29 weeks gestational age (GA) and < 1000 g. Our study included 73 infants, 41% of whom received HCT.... We found negative correlations between growth parameters and age, similar between HCT and control patients. HCT-exposed infants had lower GA but similar normalized birth weights; HCT-exposed infants a... These findings emphasize the importance of considering patient illness severity and suggest that HCT use may offer additional benefits not previously considered.... This is the first study to assess the relationship between head growth and illness severity in extremely preterm infants with extremely low birth weights during their initial NICU hospitalization. Inf...

Implementation of IT supported standardization of individualized hydrocortisone management for treatment of patients with adrenal insufficiency.

Hydrocortisone stress dosing guidelines for children with adrenal insufficiency (AI) recommend a wide range of acceptable stress doses. This has led to variability in dosing recommendations resulting ... Plan-Do-Study-Act (PDSA) cycle one aimed to address documentation of components important in AI management including body surface area (BSA), home daily dose, home stress dose, in-patient stress dose,... Initial documentation targets were met for all AI management components except for the crisis dose. The second target was only met for the home stress dose. Implementing the smart buttons aided in rea... With the assistance of technology, this quality improvement project ultimately enhanced communication through the standardization of documentation and individualized hydrocortisone stress dosing for c...

Sleep quality in patients with non-functioning pituitary adenoma: impact of replacement therapies with an emphasis on the time of hydrocortisone.

Sleep disturbances are widespread and associated with pituitary diseases, even those under long-term therapeutic management. The aim of this study was to investigate sleep quality in patients with non... Eighty-two patients with NFPA and 82 age- and gender-matched control subjects were included. Pittsburgh Sleep Quality Index (PSQI), Hospital Anxiety and Depression Scale (HADS) and International Physi... In the NFPA group, 57.3% of patients had decreased sleep quality, compared to 35.4% in the control group (p=0.005). Although there was no relationship between the presence of hydrocortisone replacemen... Our study indicated the presence of depression, and a free T4 level in the upper half of the normal range have an impact on the sleep quality of patients with NFPA. The time of hydrocortisone replacem...

Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study.

Significant practice variation exists when selecting between hydrocortisone and vasopressin as second line agents in patients with septic shock in need of escalating doses of norepinephrine. The goal ... Multicenter, retrospective, observational study.... Ten Ascension Health hospitals.... Adult patients with presumed septic shock receiving norepinephrine prior to study drug initiation between December 2015 and August 2021.... Vasopressin (0.03-0.04 units/min) or hydrocortisone (200-300 mg/day).... A total of 768 patients were included with a median (interquartile range) SOFA score of 10 (8-13), norepinephrine dose of 0.3 mcg/kg/min (0.1-0.5 mcg/kg/min), and lactate of 3.8 mmol/L (2.4-7.0 mmol/L... Addition of hydrocortisone to norepinephrine was associated with a lower 28-day mortality in patients with septic shock, compared to the addition of vasopressin....